Protelos Demonstrates Unique Long Term Osteoporotic Fracture Reduction

The results of two landmark studies announced today at the Sixth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO), confirms the evidence based, long-term efficacy of Protelos (strontium ranelate) for the reduction of nonvertebral and vertebral osteoporotic fractures over five years. This is the first time an anti-osteoporotic treatment has demonstrated fracture reduction efficacy after five years of treatment.

Recent Blog Post

Celebrating International Women's Day: Stories from Twins and TwinsUK Staff

25th March 2024 – by Aaruthy Suthahar International Women’s Day (IWD) on March 8th is a day to celebrate the...

TwinsUK part of team awarded £20 million to study bowel cancer

7th March 2024 – by TwinsUK and King’s College London TwinsUK will receive part of £20m in funding by Cancer...

Daily fibre supplement improves older adults’ brain function in just 12 weeks

29th February 2024 – By Aaruthy Suthahar Researcher’s from TwinsUK conducted a study on twins aged 60 and above has...